Sonoma Pharmaceuticals (SNOA) Non Operating Income (2013 - 2020)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Non Operating Income of $234000.0 in Q1 2020, up 274.63% quarter-over-quarter from -$134000.0 in Q4 2019, and up 73.33% on a YoY basis from $135000.0 in Q2 2019.
Sonoma Pharmaceuticals (SNOA) Non Operating Income (2013 - 2020) Analysis & Trends
Sonoma Pharmaceuticals' Non Operating Income history runs 7 years deep, the most recent figure standing at $234000.0 for Q1 2020.
- In Q1 2020, Non Operating Income rose 73.33% year-over-year to $234000.0; the TTM figure through Mar 2020 stood at $276000.0 (down 17.37% YoY), while the FY2025 annual figure was -$548000.0, down 376.77% from the prior year.
- Non Operating Income was $234000.0 for Q1 2020 at Sonoma Pharmaceuticals, up from -$134000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $234000.0 in Q1 2020 to a low of -$134000.0 in Q4 2019.
- Historically, Non Operating Income has averaged $67857.1 across 4 years, with a median of $41000.0 in 2019.
- The sharpest annual moves came in 2019 and 2020: Non Operating Income plunged 709.09% in 2019, then surged 73.33% in 2020.
- A 4-year view of Non Operating Income shows it stood at -$31000.0 in 2016, then soared by 170.97% to $22000.0 in 2018, then slumped by 709.09% to -$134000.0 in 2019, then surged by 274.63% to $234000.0 in 2020.
- The last three Non Operating Income figures came in at $234000.0 (Q1 2020), -$134000.0 (Q4 2019), and $41000.0 (Q3 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 234,000.00 |
| Dec 31, 2019 | -134,000.00 |
| Sep 30, 2019 | 41,000.00 |
| Mar 31, 2019 | 135,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Sep 30, 2018 | 208,000.00 |
| Mar 31, 2016 | -31,000.00 |
| Dec 31, 2015 | -29,000.00 |
| Sep 30, 2015 | 30,000.00 |
| Jun 30, 2015 | 30,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Sep 30, 2014 | -14,000.00 |
| Jun 30, 2014 | -31,000.00 |
| Dec 31, 2013 | -14,000.00 |